Nu Skin Enterprises (NUS) 10-Q12 Aug 142014 Q2 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
Document and Entity Information	Jun. 30, 2014	Jul. 31, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'NU SKIN ENTERPRISES INC	'
Entity Central Index Key	'0001021561	'
Current Fiscal Year End Date	'--12-31	'
Entity Well-known Seasoned Issuer	'Yes	'
Entity Voluntary Filers	'No	'
Entity Current Reporting Status	'Yes	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	59,229,867
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Jun-14	'

Consolidated_Balance_Sheets_Un

Consolidated Balance Sheets (Unaudited) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Current assets:	'	'
Cash and cash equivalents	$219,501	$525,153
Current investments	14,227	21,974
Accounts receivable	41,712	68,652
Inventories, net	389,650	339,669
Prepaid expenses and other	180,957	162,886
Total current assets	846,047	1,118,334
Property and equipment, net	429,332	396,042
Goodwill	112,446	112,446
Other intangible assets, net	79,258	83,168
Other assets	136,531	111,072
Total assets	1,603,614	1,821,062
Current liabilities:	'	'
Accounts payable	35,836	82,684
Accrued expenses	383,012	626,284
Current portion of long-term debt	99,828	67,824
Total current liabilities	518,676	776,792
Long-term debt	111,621	113,852
Other liabilities	81,559	71,799
Total liabilities	711,856	962,443
Commitments and contingencies (Note 9)	'	'
Stockholders' equity:	'	'
Class A common stock - 500 million shares authorized, $.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	410,440	397,383
Treasury stock, at cost - 31.7 million and 32.2 million shares	-844,615	-826,904
Accumulated other comprehensive loss	-42,284	-46,228
Retained earnings	1,368,126	1,334,277
Total stockholders' equity	891,758	858,619
Total liabilities and stockholders' equity	$1,603,614	$1,821,062

Consolidated_Balance_Sheets_Un1

Consolidated Balance Sheets (Unaudited) Parenthetical (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Millions, except Per Share data, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Stockholders' equity:	'	'
Common stock - authorized (in shares)	500	500
Common stock - par value (in dollars per share)	$0.00	$0.00
Common stock - issued (in shares)	90.6	90.6
Treasury stock, at cost (in shares)	31.3	31.6

Consolidated_Statements_of_Inc

Consolidated Statements of Income (Unaudited) (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Share data in Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Consolidated Statements of Income (Unaudited) [Abstract]	'	'	'	'
Revenue	$650,027	$671,328	$1,321,088	$1,212,633
Cost of sales	156,010	111,273	262,654	201,318
Gross profit	494,017	560,055	1,058,434	1,011,315
Operating expenses:	'	'	'	'
Selling expenses	283,575	297,170	596,676	530,264
General and administrative expenses	155,705	148,302	305,824	283,809
Total operating expenses	439,280	445,472	902,500	814,073
Operating income	54,737	114,583	155,934	197,242
Other income (expense), net	-21,119	-1,187	-38,627	-1,075
Income before provision for income taxes	33,618	113,396	117,307	196,167
Provision for income taxes	14,111	38,961	42,946	67,450
Net income	$19,507	$74,435	$74,361	$128,717
Net income per share (Note 2):	'	'	'	'
Basic (in dollars per share)	$0.33	$1.27	$1.26	$2.20
Diluted (in dollars per share)	$0.32	$1.22	$1.22	$2.11
Weighted-average common shares outstanding (000s):	'	'	'	'
Basic (in shares)	59,052	58,620	58,961	58,487
Diluted (in shares)	61,118	61,121	61,177	60,882

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Consolidated Statements of Comprehensive Income [Abstract]	'	'	'	'
Net Income (Loss) Attributable to Parent	$19,507	$74,435	$74,361	$128,717
Other Comprehensive Income (Loss), Net of Tax [Abstract]	'	'	'	'
Foreign currency translation adjustment	3,112	426	4,970	-2,947
Net unrealized gains/(losses) on foreign currency cash flow hedges	-326	575	-583	1,561
Less: Reclassification adjustment for realized losses/gains in current earnings	-207	-901	-443	-2,064
Total	2,579	100	3,944	-3,450
Comprehensive Income	$22,086	$74,535	$78,305	$125,267

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:	'	'
Net income	$74,361	$128,717
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	24,965	15,527
Foreign currency (gains)/losses	48,264	863
Stock-based compensation	13,726	11,411
Deferred taxes	3,871	-2,901
Changes in operating assets and liabilities:	'	'
Accounts receivable	27,121	-24,647
Inventories, net	-54,218	-45,228
Prepaid expenses and other	-31,157	-25,515
Other assets	-14,797	-10,987
Accounts payable	-46,503	3,593
Accrued expenses	-233,532	132,787
Other liabilities	3,034	5,237
Net cash provided by operating activities	-184,865	188,857
Cash flows from investing activities:	'	'
Purchases of property and equipment	-57,136	-82,515
Proceeds of investment sales	22,011	9,701
Purchases of investments	-13,655	-5,077
Net cash used in investing activities	-48,780	-77,891
Cash flows from financing activities:	'	'
Exercise of employee stock options	-2,656	7,359
Payment of debt	-39,915	-13,890
Payment of cash dividends	-40,511	-35,140
Income tax benefit of options exercised	9,267	7,309
Proceeds from debt	65,680	35,000
Repurchases of shares of common stock	-25,002	-14,615
Net cash used in financing activities	-33,137	-13,977
Effect of exchange rate changes on cash	-38,870	-14,336
Net increase in cash and cash equivalents	-305,652	82,653
Cash and cash equivalents, beginning of period	525,153	320,025
Cash and cash equivalents, end of period	$219,501	$402,678

THE_COMPANY

THE COMPANY	6 Months Ended
	Jun. 30, 2014
THE COMPANY [Abstract]	'
THE COMPANY	'
	1	THE COMPANY

	Nu Skin Enterprises, Inc. (the "Company") is a leading, global direct selling company that develops and distributes premium-quality, innovative personal care products and nutritional supplements that are sold worldwide under the Nu Skin and Pharmanex brands and a small number of other products and services. Over the last five years, the Company has introduced new Pharmanex nutritional supplements and Nu Skin personal care products un der its ageLOC anti-aging brand. The Company reports revenue from five geographic regions: Greater China, which consists of Mainland China, Hong Kong, Macau and Taiwan; North Asia, which consists of Japan and South Korea; South Asia/Pacific, which consists of Australia, Brunei, French Polynesia, Indonesia, Malaysia, New Caledonia, New Zealand, the Philippines, Singapore, Thailand and Vietnam; Americas, which consists of the United States, Canada and Latin America; and Europe, Middle East and Africa ("EMEA"), which consists of several markets in Europe as well as Israel, Russia and South Africa (the Company's subsidiaries operating in these countries are collectively referred to as the "Subsidiaries").

	The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company's financial information as of June 30, 2014, and for the three- and six-month periods ended June 30, 2014 and 2013. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2013.

NET_INCOME_PER_SHARE

NET INCOME PER SHARE	6 Months Ended
	Jun. 30, 2014
NET INCOME PER SHARE [Abstract]	'
NET INCOME PER SHARE	'
	2	NET INCOME PER SHARE

	Net income per share is computed based on the weighted-average number of common shares outstanding during the periods presented. Additionally, diluted earnings per share data gives effect to all potentially dilutive common shares that were outstanding during the periods presented. For the three-month periods ended June 30, 2014 and 2013, other stock options of 2.1 million and 0.1 million, respectively, and for the six-month periods ended June 30, 2014 and 2013, other stock options of 2.1 million and 0.2 million, respectively, were excluded from the calculation of diluted earnings per share because they were anti-dilutive.

DIVIDENDS_PER_SHARE

DIVIDENDS PER SHARE	6 Months Ended
	Jun. 30, 2014
DIVIDENDS PER SHARE [Abstract]	'
DIVIDENDS PER SHARE	'
	3	DIVIDENDS PER SHARE

	In March and May 2014, the Company's board of directors declared a quarterly cash dividend of $0.345 per share. These quarterly cash dividends of $20.1 million and $20.4 million were paid on March 26, 2014 and June 11, 2014, to stockholders of record on March 14, 2014 and May 23, 2014.

DERIVATIVE_FINANCIAL_INSTRUMEN

DERIVATIVE FINANCIAL INSTRUMENTS	6 Months Ended
	Jun. 30, 2014
DERIVATIVE FINANCIAL INSTRUMENTS [Abstract]	'
DERIVATIVE FINANCIAL INSTRUMENTS	'
	4	DERIVATIVE FINANCIAL INSTRUMENTS

	The Company held mark-to-market forward contracts designated as foreign currency cash flow hedges with notional amounts of 1.9 billion Japanese yen and 10.0 million euros ($18.7 million and $13.7 million, respectively) as of June 30, 2014 and 2.9 billion Japanese yen ($29.2 million) and no euros as of June 30, 2013 to hedge forecasted foreign-currency-denominated intercompany transactions.

	The contracts held at June 30, 2014 have maturities through April 2015 and accordingly, all unrealized gains and losses on foreign currency cash flow hedges included in accumulated other comprehensive loss will be recognized in current earnings over the next 12 months. The pre-tax net gains on foreign currency cash flow hedges reclassified from accumulated other comprehensive loss to revenue were $0.3 million and $1.4 million, respectively for the three-month periods ended June 30, 2014 and 2013 and $0.7 million and $3.2 million, respectively, for the six-month periods ended June 30, 2014 and 2013. The corresponding tax effects of these transactions were recorded in provision for income tax expense. As of June 30, 2014 and December 31, 2013, there were $0.2 million and $1.3 million, respectively, of unrealized gains included in accumulated other comprehensive loss related to foreign currency cash flow hedges. The remaining $42.5 million and $47.5 million as of June 30, 2014 and December 31, 2013, respectively, in accumulated other comprehensive loss are related to cumulative translation adjustments.

REPURCHASES_OF_COMMON_STOCK

REPURCHASES OF COMMON STOCK	6 Months Ended
	Jun. 30, 2014
REPURCHASES OF COMMON STOCK [Abstract]	'
REPURCHASES OF COMMON STOCK	'
	5	REPURCHASES OF COMMON STOCK

	During the three-month periods ended June 30, 2014 and 2013, the Company did not repurchase shares of its Class A common stock under its open market stock repurchase plan. During the six-month periods ended June 30, 2014 and 2013, the Company repurchased approximately 0.3 million and 0.4 million shares of its Class A common stock under its open market repurchase plan for $25.0 million and $14.6 million, respectively. As of June 30, 2014, $369.5 million was available for repurchases under the open market stock repurchase program.

SEGMENT_INFORMATION

SEGMENT INFORMATION	6 Months Ended
SEGMENT INFORMATION	Jun. 30, 2014
SEGMENT INFORMATION [Abstract]	'
SEGMENT INFORMATION	'
	6	SEGMENT INFORMATION

	The Company operates in a single operating segment by selling products through a global network of independent distributors that operates in a seamless manner from market to market, except for its operations in Mainland China. In Mainland China, the Company utilizes sales employees, contractual sales promoters, and independent direct sellers to distribute its products. Contractual sales promoters sell products in similar fashion to the Company's sales employees, but act as independent agents to sell products through its retail stores and website. Independent direct sellers can sell away from the Company's stores in jurisdictions where the Company has obtained a direct sales license to do so. Selling expenses are the Company's largest expense comprised of the commissions paid to its worldwide independent distributors as well as remuneration to its sales force in Mainland China. The Company manages its business primarily by managing its sales force. The Company does not use profitability reports on a regional or divisional basis for making business decisions. However, the Company does report revenue in five geographic regions: Greater China, North Asia, Americas, South Asia/Pacific and EMEA.

	Revenue generated in each of these regions is set forth below (U.S. dollars in thousands):

			Three Months Ended				Six Months Ended
			June 30,				June 30,
	Revenue:		2014		2013		2014		2013

	Greater China	$	229,869	$	261,241	$	508,798	$	432,063
	North Asia		195,995		194,812		391,456		380,722
	Americas		89,911		83,433		169,820		159,125
	South Asia/Pacific		81,653		85,582		152,847		152,539
	EMEA		52,599		46,260		98,167		88,184
	Totals	$	650,027	$	671,328	$	1,321,088	$	1,212,633

	Revenue generated by each of the Company's product lines is set forth below (U.S. dollars in thousands):

			Three Months Ended				Six Months Ended
			June 30,				June 30,
	Revenue:		2014		2013		2014		2013

	Nu Skin	$	391,968	$	411,220	$	794,079	$	732,660
	Pharmanex		256,216		258,862		523,488		477,213
	Other		1,843		1,246		3,521		2,760
	Totals	$	650,027	$	671,328	$	1,321,088	$	1,212,633

	Additional information as to the Company's operations in its most significant geographic areas is set forth below (U.S. dollars in thousands):

			Three Months Ended				Six Months Ended
			June 30,				June 30,
	Revenue:		2014		2013		2014		2013

	Mainland China	$	153,795	$	190,383	$	366,012	$	310,048
	South Korea		118,797		97,420		232,797		178,515
	Japan		77,198		97,392		158,659		202,207
	United States		61,056		61,627		115,878		118,674
	Taiwan		41,664		37,824		77,428		69,950
	Hong Kong		34,410		33,034		65,358		52,065
	Malaysia		23,256		27,797		42,305		45,840


	Long-lived assets:		30-Jun-14		31-Dec-13

	Mainland China	$	95,552	$	82,726
	South Korea		24,834		14,345
	Japan		12,629		9,970
	United States		281,426		273,388
	Taiwan		1,939		1,928
	Hong Kong		2,282		2,497
	Malaysia		1,267		1,463

DEFERRED_TAX_ASSETS_AND_LIABIL

DEFERRED TAX ASSETS AND LIABILITIES	6 Months Ended
	Jun. 30, 2014
DEFERRED TAX ASSETS AND LIABILITIES [Abstract]	'
DEFERRED TAX ASSETS AND LIABILITIES	'
	7	DEFERRED TAX ASSETS AND LIABILITIES

	The Company accounts for income taxes in accordance with the Income Taxes Topic of the Financial Accounting Standards Codification. These standards establish financial accounting and reporting standards for the effects of income taxes that result from an enterprise's activities during the current and preceding years. The Company takes an asset and liability approach for financial accounting and reporting of income taxes. The Company pays income taxes in many foreign jurisdictions based on the profits realized in those jurisdictions, which can be significantly impacted by terms of intercompany transactions between the Company and its foreign affiliates. Deferred tax assets and liabilities are created in this process. As of June 30, 2014, the Company had net deferred tax assets of $61.7 million. The Company has netted these deferred tax assets and deferred tax liabilities by jurisdiction. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized.

	The Company evaluates its indefinite reinvestment assertions with respect to foreign earnings for each quarter. Other than earnings the Company intends to reinvest indefinitely, the Company accrues for the U.S. federal, state and foreign income tax applicable to the earnings. Undistributed earnings that the Company has indefinitely reinvested, and for which no federal income taxes in the U.S. have been provided, aggregate to $50.0 million as of June 30, 2014 and December 31, 2013. In the event that all non-U.S. subsidiaries' undistributed earnings, which the Company has designated as indefinitely reinvested, were remitted to the United States to fund operating and capital plans, regulatory capital requirements, parent company financing or cash flow needs, the amount of incremental taxes would be approximately $5.5 million.

UNCERTAIN_TAX_POSITIONS

UNCERTAIN TAX POSITIONS	6 Months Ended
	Jun. 30, 2014
UNCERTAIN TAX POSITIONS [Abstract]	'
UNCERTAIN TAX POSITIONS	'
	8	UNCERTAIN TAX POSITIONS

	The Company files income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions. The Company is no longer subject to tax examinations from the United States Internal Revenue Service (the "IRS") for any years for which tax returns have been filed except for 2011. With a few exceptions, the Company is no longer subject to state and local income tax examination by tax authorities for the years before 2008. In 2009, the Company entered into a voluntary program with the IRS called Compliance Assurance Process ("CAP"). The objective of CAP is to contemporaneously work with the IRS to achieve federal tax compliance and resolve all or most of the issues prior to filing of the tax return. The Company has elected to participate in the CAP program for 2014 and may elect to continue participating in CAP for future tax years; the Company may withdraw from the program at any time. In major foreign jurisdictions, the Company is no longer subject to income tax examinations for years before 2007. Along with the IRS examination of 2011, the Company is currently under examination in certain foreign jurisdictions; however, the outcomes of those reviews are not yet determinable.

	The Company's unrecognized tax benefits relate to multiple foreign and domestic jurisdictions. Due to potential increases in unrecognized tax benefits from the multiple jurisdictions in which the Company operates, as well as the expiration of various statutes of limitation, it is reasonably possible that the Company's gross unrecognized tax benefits, net of foreign currency adjustments, may decrease within the next 12 months by a range of approximately $3 to $4 million.

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2014
COMMITMENTS AND CONTINGENCIES [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	9	COMMITMENTS AND CONTINGENCIES

	The Company is subject to governmental regulations pertaining to product formulation, labeling and packaging, product claims and advertising and to the Company's direct selling system. The Company is also subject to the jurisdiction of numerous foreign tax and customs authorities. Any assertions or determination that either the Company or the Company's sales force is not in compliance with existing statutes, laws, rules or regulations could have a material adverse effect on the Company's operations. In addition, in any country or jurisdiction, the adoption of new statutes, laws, rules or regulations or changes in the interpretation of existing statutes, laws, rules or regulations could have a material adverse effect on the Company and its operations. Although management believes that the Company is in compliance in all material respects with the statutes, laws, rules and regulations of every jurisdiction in which it operates, no assurance can be given that the Company's compliance with applicable statutes, laws, rules and regulations will not be challenged by foreign authorities or that such challenges will not have a material adverse effect on the Company's financial position or results of operations or cash flows. The Company and its Subsidiaries are defendants in litigation and proceedings involving various matters. Except as noted below, in the opinion of the Company's management, based upon advice of its counsel handling such litigation and proceedings, adverse outcomes, if any, will not likely result in a material effect on the Company's consolidated financial condition, results of operations or cash flows.

	The Company is subject to regular audits by federal, state and foreign tax authorities. These audits may result in additional tax liabilities. The Company believes it has appropriately provided for income taxes for all years. Several factors drive the calculation of its tax reserves. Some of these factors include: (i) the expiration of various statutes of limitations; (ii) changes in tax law and regulations; (iii) issuance of tax rulings; and (iv) settlements with tax authorities. Changes in any of these factors may result in adjustments to the Company's reserves, which would impact its reported financial results.

	The Company is currently involved in a dispute related to customs assessments by Yokohama Customs on several of the Company's products for the period of October 2006 through September 2009 in connection with post-importation audits, as well as the disputed portion of the Company's import duties from October 2009 to the present, which the Company has or will hold in bond or pay under protest. Additional assessments related to any prior period are barred by applicable statutes of limitations. The aggregate amount of these assessments and disputed duties was approximately 4.3 billion Japanese yen as of June 30, 2014 (approximately $42.1 million), net of any recovery of consumption taxes. The issue in this case is whether a United States entity utilizing a commissionaire agent in Japan to import its products can use the manufacturer's invoice or must use another valuation method, and, if an alternative method must be used, what the allowable deductions would be in determining the proper valuation. Following the Company's review of the assessments and after consulting with the Company's legal and customs advisors, the Company believes that the additional assessments are improper and are not supported by applicable customs laws. The Company filed letters of protest with the applicable Customs authorities, which were rejected. The Company then appealed the matter to the Ministry of Finance in Japan. In the second quarter of 2011, the Ministry of Finance in Japan denied the Company's administrative appeal. The Company disagrees with the Ministry of Finance's administrative decision. The Company is now pursuing the matter in Tokyo District Court, which the Company believes will provide a more independent determination of the matter. In addition, the Company is currently being required to post a bond or make a deposit to secure any additional duties that may be due and payable on these current imports. Because the Company believes that the assessment of higher duties by the customs authorities is an improper application of the regulations, the Company is currently expensing the portion of the duties the Company believes is supported under applicable customs law, and recording the additional deposit or payment as a receivable within long-term assets on its consolidated financial statements. If the Company is unsuccessful in recovering the amounts assessed and paid, the Company will record a non-cash expense for the full amount of the disputed assessments. The Company anticipates that additional disputed duties will be limited going forward as the Company has entered into an arrangement to purchase a majority of the affected products in Japan from a Japanese company that purchases and imports the products from the manufacturers.

	In addition, the Company is currently being sued in a purported class action lawsuit and derivative claim relating to negative media and regulatory scrutiny regarding the Company's business in Mainland China and the associated decline in the Company's stock price. These lawsuits, or others filed alleging similar facts, could result in monetary or other penalties that may affect the Company's operating results and financial condition.

DEBT

DEBT	6 Months Ended
	Jun. 30, 2014
DEBT [Abstract]	'
DEBT	'
	10	DEBT


	The Company currently has debt pursuant to various credit facilities and other borrowings. The Company's book value for both the individual and consolidated debt included in the table below approximates fair value. The estimated fair value of the Company's debt is based on interest rates available for debt with similar terms and remaining maturities. The Company has classified these instruments as Level 2 in the fair value hierarchy. The following table summarizes the Company's debt facilities:

	Debt Facility		Original Principal Amount	Balance as of	Balance as of	Interest Rate	Repayment terms
				June 30, 2014⁽¹⁾	December 31, 2013

	Multi-currency uncommitted
	shelf facility⁽²⁾:

	U.S. dollar		$40.0 million	$17.1 million	$17.1 million	6.20%	Notes due July 2016 with annual principal payments that began in July 2010.
	denominated:

			$20.0 million	$8.6 million	$11.4 million	6.20%	Notes due January 2017 with annual principal payments that began in January 2011.


	Japanese yen		3.1 billion yen	―	0.4 billion yen or $4.1 million	1.70%	Notes paid in full on April 30, 2014.
	denominated:

			2.3 billion yen	1.3 billion yen or $12.8 million	1.3 billion yen or $12.3 million	2.60%	Notes due September 2017 with annual principal payments that began in September 2011.


			2.2 billion yen	0.9 billion yen or $9.2 million	1.2 billion yen or $11.8 million	3.30%	Notes due January 2017 with annual principal payments that began in January 2011.


			8.0 billion yen	8.0 billion yen or $78.7 million	8.0 billion yen or $75.8 million	1.70%	Notes due May 2022 with annual principal payments that begin in May 2016.

	Revolving credit facilities:

	2010⁽³⁾			$35.0 million⁽³⁾	$35.0 million	Variable 30 day:	Revolving line of credit expired August 8, 2014.
						0.66%

	2013			$50.0 million	$14.0 million	Variable 30 day:	Revolving line of credit expires September 2014.
						0.58%

	2014⁽⁴⁾			―	―	N/A	Revolving line of credit expires April 2015



	-1	As of June 30, 2014, the current portion of the Company's debt (i.e. becoming due in the next 12 months) includes $6.2 million of the balance of its Japanese yen-denominated debt under the multi-currency uncommitted shelf facility, $8.6 million of the balance on its U.S. dollar denominated debt under the multi-currency uncommitted shelf facility and $85.0 million of the Company's revolving loans.

	-2	On August 8, 2014, the Company entered into an amendment of the amended and restated note purchase and private shelf agreement (multi-currency), dated as of May 25, 2012, among the Company, Prudential Investment Management, Inc. and certain other purchasers. The amendment modified the restricted payments covenant to allow the aggregate amount of restricted payments to exceed the allowed threshold by no more than $110 million for the quarter ending June 30, 2014, to avoid default or acceleration provisions of the agreement.

	-3	The Company paid the outstanding balance in full prior to the August 8, 2014 expiration of the amended and restated credit agreement, dated as of May 25, 2012, among the Company, various financial institutions, and JPMorgan Chase Bank, N.A. as administrative agent.

	-4	On April 9, 2014, the Company entered into an additional 364 day revolving line of credit with Bank of America, N.A. with a commitment amount of $50 million and an interest rate equal to 1 month LIBOR plus 95.0 basis points. The Company has not drawn on this revolving line of credit as of the date hereof.

ACCOUNTING_PRONOUNCEMENTS

ACCOUNTING PRONOUNCEMENTS	6 Months Ended
	Jun. 30, 2014
ACCOUNTING PRONOUNCEMENTS [Abstract]	'
ACCOUNTING PRONOUNCEMENTS	'
	11	ACCOUNTING PRONOUNCEMENTS

	In July 2013, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (a consensus of the Emerging Issues Task Force). This ASU addresses when unrecognized tax benefits should be presented as reductions to deferred tax assets for net operating loss carryforwards in the financial statements. This ASU is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013. The adoption of ASU 2013-11 did not have a material impact on the Company's consolidated financial position, results of operations or cash flows.

	In April 2014, the FASB issued ASU No. 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. This ASU changes the threshold for a disposal to qualify as a discontinued operation. To be considered a discontinued operation a disposal now must represent a strategic shift that has or will have a major effect on an entity's operations and financial results. This ASU also requires new disclosures for individually material disposal transactions that do not meet the definition of a discontinued operation. This update will be applied prospectively and is effective for annual periods, and interim periods within those years, beginning after December 15, 2014. Early adoption is permitted provided the disposal was not previously disclosed. The adoption of this guidance is not expected to have a material impact on the Company's consolidated financial statements.

	In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). The new revenue recognition standard provides a five-step analysis of transactions to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU is effective for annual periods beginning after December 15, 2016 and shall be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. The Company is evaluating the potential impact of this adoption on its consolidated financial statements.
	In June 2014, the FASB issued ASU No. 2014-12, Compensation—Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force). This ASU clarifies that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in Topic 718 as it relates to awards with performance conditions that affect vesting to account for such awards. As such, the performance target should not be reflected in estimating the grant-date fair value of the award. Compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. This ASU is effective for annual periods, and interim periods within those years, beginning after December 15, 2015. Early adoption is permitted. This ASU may be applied either (a) prospectively to all awards granted or modified after the effective date or (b) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter. The Company is evaluating the potential impact of this adoption on its consolidated financial statements.

REVISIONS

REVISIONS	6 Months Ended
	Jun. 30, 2014
REVISIONS [Abstract]	'
REVISIONS	'
	12	REVISIONS

	The presentation of the Company's consolidated statements of income for the three- and six-month periods ended June 30, 2013, was revised to reduce the selling expense and revenue by $11.6 million and $20.4 million related to an error in the classification of selling rebates. The revision had no effect on the operating income, net income or comprehensive income, the consolidated balance sheet or cash flows. The revision was not considered to be material to the previously issued financial statements.

VENEZUELA_HIGHLY_INFLATIONARY_

VENEZUELA HIGHLY INFLATIONARY ACCOUNTING	6 Months Ended
VENEZUELA HIGHLY INFLATIONARY ACCOUNTING	Jun. 30, 2014
VENEZUELA HIGHLY INFLATIONARY ACCOUNTING [Abstract]	'
VENEZUELA HIGHLY INFLATIONARY ACCOUNTING	'
	13. VENEZUELA HIGHLY INFLATIONARY ACCOUNTING

	The Company commenced operations in Venezuela in 2007, where it markets a variety of personal care and nutritional products. Total assets in Venezuela as of June 30, 2014 are $7.4 million, $5.8 of which are monetary assets. The Venezuela subsidiary also has a $27.1 million intercompany balance to its parent company as of June 30, 2014, with respect to charges for inventory, commissions, license fees and service fees. The Company imports all of its products into Venezuela from the United States. Venezuela represents a very small portion of the Company's overall business with sales for the six months ended June 30, 2014 representing less than 2% of the Company's overall revenue.

	Since November of 2009, Venezuela has been considered a highly inflationary economy. A country is considered to have a highly inflationary economy if it has a cumulative inflation rate of approximately 100% or more over a three-year period as well as other qualitative factors including historic inflation rate trends (increasing and decreasing), the capital intensiveness of the operation and other pertinent economic factors. The functional currency in highly inflationary economies is required to be the functional currency of the entity's parent company (which for our Venezuela subsidiary is the U.S. dollar), and transactions denominated in the local currency are re-measured to the functional currency. The remeasurement of bolivars into U.S. dollars creates foreign currency transaction gains or losses, which should be included in the Company's consolidated statement of income.

	The Venezuela subsidiary did not transition to highly inflationary status until the first quarter of 2014. As a result, the Company continued to account for the Venezuela subsidiary as a bolivar functional currency entity, rather than a U.S. dollar functional currency entity. In the first quarter of 2014, the Company began to account for this subsidiary as highly inflationary, and therefore changed the functional currency of the entity to the U.S. dollar. As a result, for periods prior to 2014, the Company improperly recorded $6 million related to foreign currency remeasurement adjustments caused by changes in the Venezuela exchange rate in accumulated other comprehensive income (equity). The consolidated statement of income for the six-month period ended June 30, 2014, includes an out-of-period adjustment of $6 million to correct this error. The Company has determined not to restate prior period financial statements because the amount of the adjustment is not material to the prior periods or this reporting period.

	The current operating environment in Venezuela continues to be challenging, with high inflation in the country, government restrictions on foreign exchange and pricing controls, and the possibility of the government announcing further devaluations to its currency. Currency restrictions enacted by the Venezuelan government have impacted the ability of the Company to exchange foreign currency at the official rate to pay for imported products, license fees, commissions and other service fees. The Company has been unsuccessful in obtaining U.S. dollars at the official exchange rates and under alternative exchange mechanisms described below. As a result, these foreign exchange controls in Venezuela have limited the Company's ability to repatriate earnings and settle the Company's intercompany obligations, which has resulted in the accumulation of bolivar-denominated cash and cash equivalents in Venezuela.

	During the first quarter of 2014, two new foreign exchange mechanisms ("SICAD I" and "SICAD II") became available in Venezuela. Accordingly, there are three legal mechanisms in Venezuela to exchange currency. As of March 31, 2014, the Company determined it would be most appropriate for it to utilize the SICAD I rate, which was approximately 10.7 bolivars per U.S. dollar. As a result of the adoption of this rate during the period ended March 31, 2014, the consolidated statements of income for the six-months ended June 30, 2014 include a $15 million charge in Other Income (Expense) to reflect foreign currency transaction losses on its net monetary assets denominated in bolivar.

	As of June 30, 2014, the Company determined that it would be most appropriate for it to utilize the SICAD II rate, which was approximately 50 bolivars per U.S. dollar, as the Company had not been successful in getting approval under SICAD I and believed the SICAD II rate better reflects the rate at which the Company will be able to convert bolivars to U.S. dollars. As a result of the adoption of this rate during the three months ended June 30, 2014, the Company recorded an additional $25 million charge in Other Income (Expense) to reflect additional foreign currency translation losses on its net monetary assets denominated in bolivar, which is reflected in the three- and six-month periods ended June 30, 2014.

ADJUSTMENT_TO_INVENTORY

ADJUSTMENT TO INVENTORY	6 Months Ended
ADJUSTMENT TO INVENTORY	Jun. 30, 2014
ADJUSTMENT TO INVENTORY [Abstract]	'
ADJUSTMENT TO INVENTORY	'
	14. ADJUSTMENT TO INVENTORY

	During the second quarter of 2014, the Company made a determination to adjust its inventory carrying value. Heightened media and regulatory scrutiny in Mainland China in the first part of 2014, and the voluntary actions the Company took in response to such scrutiny, had a negative impact on the size of the Company's limited-time offer in June, which significantly reduced its expectations for plans to sell TR90 in a limited-time offer later in 2014 or the beginning of 2015. This resulted in a $50 million write-down of estimated surplus inventory in Mainland China. Total adjustments to the Company's inventory carrying value as of June 30, 2014 and December 31, 2013 were $58.0 million and $5.9 million, respectively.

SUBSEQUENT_EVENT

SUBSEQUENT EVENT	6 Months Ended
	Jun. 30, 2014
SUBSEQUENT EVENT [Abstract]	'
SUBSEQUENT EVENT	'
	15	SUBSEQUENT EVENTS

	As of June 30, 2014, the Company was in violation of its restricted payments covenant under its amended and restated note purchase and private shelf agreement (multi-currency), dated as of May 25, 2012, among the Company, Prudential Investment Management, Inc. and certain other purchasers, as amended (the "Prudential Agreement") and the amended and restated credit agreement, dated as of May 25, 2012, among the Company, various financial institutions, and JPMorgan Chase Bank, N.A. as administrative agent (the "JPMC Agreement"), which restricts the Company from making dividend payments or stock repurchases to the extent the aggregate amount of such payments exceed $100 million plus the cumulative cash flow from operations less capital investments since June 30, 2012. Effective August 8, 2014, the Company entered into an amendment of the Prudential Agreement that allows the aggregate amount of restricted payments to exceed the allowed threshold by no more than $110 million for the quarter ending June 30, 2014 and $50 million for the quarter ending September 30, 2014, to avoid default or acceleration provisions of the Prudential Agreement. The JPMC Agreement expired pursuant to its terms on August 8, 2014, prior to which all amounts outstanding thereunder were repaid in full.

	In July 2014, the Company's subsidiary in Japan borrowed 3 billion Japanese yen (approximately $30.0 million), which is due on September 30, 2014. In July 2014, the Company's subsidiary in South Korea borrowed $20.0 million, which is due in December 2014, with a right to extend the term for an additional six months.

SEGMENT_INFORMATION_Tables

SEGMENT INFORMATION (Tables)	6 Months Ended
SEGMENT INFORMATION (Tables)	Jun. 30, 2014
SEGMENT INFORMATION [Abstract]	'
Revenue and Long-Lived Assets by Geographic Region	'
	Revenue generated in each of these regions is set forth below (U.S. dollars in thousands):

			Three Months Ended				Six Months Ended
			June 30,				June 30,
	Revenue:		2014		2013		2014		2013

	Greater China	$	229,869	$	261,241	$	508,798	$	432,063
	North Asia		195,995		194,812		391,456		380,722
	Americas		89,911		83,433		169,820		159,125
	South Asia/Pacific		81,653		85,582		152,847		152,539
	EMEA		52,599		46,260		98,167		88,184
	Totals	$	650,027	$	671,328	$	1,321,088	$	1,212,633
Revenue Generated by Each of the Company's Major Product Lines	'
	Revenue generated by each of the Company's product lines is set forth below (U.S. dollars in thousands):

			Three Months Ended				Six Months Ended
			June 30,				June 30,
	Revenue:		2014		2013		2014		2013

	Nu Skin	$	391,968	$	411,220	$	794,079	$	732,660
	Pharmanex		256,216		258,862		523,488		477,213
	Other		1,843		1,246		3,521		2,760
	Totals	$	650,027	$	671,328	$	1,321,088	$	1,212,633
Revenue and long-lived assets by significant geographic area	'
	Additional information as to the Company's operations in its most significant geographic areas is set forth below (U.S. dollars in thousands):

			Three Months Ended				Six Months Ended
			June 30,				June 30,
	Revenue:		2014		2013		2014		2013

	Mainland China	$	153,795	$	190,383	$	366,012	$	310,048
	South Korea		118,797		97,420		232,797		178,515
	Japan		77,198		97,392		158,659		202,207
	United States		61,056		61,627		115,878		118,674
	Taiwan		41,664		37,824		77,428		69,950
	Hong Kong		34,410		33,034		65,358		52,065
	Malaysia		23,256		27,797		42,305		45,840


	Long-lived assets:		30-Jun-14		31-Dec-13

	Mainland China	$	95,552	$	82,726
	South Korea		24,834		14,345
	Japan		12,629		9,970
	United States		281,426		273,388
	Taiwan		1,939		1,928
	Hong Kong		2,282		2,497
	Malaysia		1,267		1,463

DEBT_Tables

DEBT (Tables)	6 Months Ended
	Jun. 30, 2014
DEBT [Abstract]	'
Summary of Debt Arrangements	'

	The Company currently has debt pursuant to various credit facilities and other borrowings. The Company's book value for both the individual and consolidated debt included in the table below approximates fair value. The estimated fair value of the Company's debt is based on interest rates available for debt with similar terms and remaining maturities. The Company has classified these instruments as Level 2 in the fair value hierarchy. The following table summarizes the Company's debt facilities:

	Debt Facility		Original Principal Amount	Balance as of	Balance as of	Interest Rate	Repayment terms
				June 30, 2014⁽¹⁾	December 31, 2013

	Multi-currency uncommitted
	shelf facility⁽²⁾:

	U.S. dollar		$40.0 million	$17.1 million	$17.1 million	6.20%	Notes due July 2016 with annual principal payments that began in July 2010.
	denominated:

			$20.0 million	$8.6 million	$11.4 million	6.20%	Notes due January 2017 with annual principal payments that began in January 2011.


	Japanese yen		3.1 billion yen	―	0.4 billion yen or $4.1 million	1.70%	Notes paid in full on April 30, 2014.
	denominated:

			2.3 billion yen	1.3 billion yen or $12.8 million	1.3 billion yen or $12.3 million	2.60%	Notes due September 2017 with annual principal payments that began in September 2011.


			2.2 billion yen	0.9 billion yen or $9.2 million	1.2 billion yen or $11.8 million	3.30%	Notes due January 2017 with annual principal payments that began in January 2011.


			8.0 billion yen	8.0 billion yen or $78.7 million	8.0 billion yen or $75.8 million	1.70%	Notes due May 2022 with annual principal payments that begin in May 2016.

	Revolving credit facilities:

	2010⁽³⁾			$35.0 million⁽³⁾	$35.0 million	Variable 30 day:	Revolving line of credit expired August 8, 2014.
						0.66%

	2013			$50.0 million	$14.0 million	Variable 30 day:	Revolving line of credit expires September 2014.
						0.58%

	2014⁽⁴⁾			―	―	N/A	Revolving line of credit expires April 2015



	-1	As of June 30, 2014, the current portion of the Company's debt (i.e. becoming due in the next 12 months) includes $6.2 million of the balance of its Japanese yen-denominated debt under the multi-currency uncommitted shelf facility, $8.6 million of the balance on its U.S. dollar denominated debt under the multi-currency uncommitted shelf facility and $85.0 million of the Company's revolving loans.

	-2	On August 8, 2014, the Company entered into an amendment of the amended and restated note purchase and private shelf agreement (multi-currency), dated as of May 25, 2012, among the Company, Prudential Investment Management, Inc. and certain other purchasers. The amendment modified the restricted payments covenant to allow the aggregate amount of restricted payments to exceed the allowed threshold by no more than $110 million for the quarter ending June 30, 2014, to avoid default or acceleration provisions of the agreement.

	-3	The Company paid the outstanding balance in full prior to the August 8, 2014 expiration of the amended and restated credit agreement, dated as of May 25, 2012, among the Company, various financial institutions, and JPMorgan Chase Bank, N.A. as administrative agent.

	-4	On April 9, 2014, the Company entered into an additional 364 day revolving line of credit with Bank of America, N.A. with a commitment amount of $50 million and an interest rate equal to 1 month LIBOR plus 95.0 basis points. The Company has not drawn on this revolving line of credit as of the date hereof.

THE_COMPANY_Details

THE COMPANY (Details)	6 Months Ended
	Jun. 30, 2014
	Region
THE COMPANY [Abstract]	'
Number of geographic regions	5

NET_INCOME_PER_SHARE_Details

NET INCOME PER SHARE (Details)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
NET INCOME PER SHARE [Abstract]	'	'	'	'
Other shares excluded from the calculation of diluted earnings per share (in shares)	2.1	0.1	2.1	0.2

DIVIDENDS_PER_SHARE_Details

DIVIDENDS PER SHARE (Details) (USD $)	3 Months Ended			6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014	Mar. 31, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
DIVIDENDS PER SHARE [Abstract]	'	'	'	'	'
Date declared	'2014-05	'	'2014-03	'2014-05	'2014-03
Cash dividend declared (in dollars per share)	$0.35	'	$0.35	'	'
Payment of cash dividends	$20,355	$20,141,000	'	$40,511	$35,140
Date paid	11-Jun-14	'	26-Mar-14	'	'
Date of record	23-May-14	'	14-Mar-14	'	'

DERIVATIVE_FINANCIAL_INSTRUMEN1

DERIVATIVE FINANCIAL INSTRUMENTS (Details)

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

USD ($)

Accumulated Unrealized Gains (Losses) on Foreign Currency Cash Flow Hedges [Member]

Accumulated Translation Adjustment [Member]

Forward Contracts [Member]

USD ($)

Reclassification out of Accumulated Other Comprehensive Income [Member]

USD ($)

Cash Flow Hedges [Member]

USD ($)

Japanese Yen [Member]

Euros [Member]

USD ($)

JPY (¥)

USD ($)

JPY (¥)

USD ($)

EUR (€)

Derivative [Line Items]

Notional amount

$18,700,000

¥ 1,900,000,000

$29,200,000

¥ 2,900,000,000

$13,700,000

€ 10,000,000

€ 0

Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]

Revenue

650,027,000

671,328,000

1,321,088,000

1,212,633,000

300,000

1,400,000

700,000

3,200,000

Accumulated Other Comprehensive Income (Loss) [Line Items]

Accumulated other comprehensive income (loss)

($42,284,000)

($46,228,000)

$200,000

$1,300,000

($42,500,000)

($47,500,000)

REPURCHASES_OF_COMMON_STOCK_De

REPURCHASES OF COMMON STOCK (Details) (USD $)	3 Months Ended	6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2013	Jun. 30, 2013	Jun. 30, 2014
Equity, Class of Treasury Stock [Line Items]	'	'	'
Common stock repurchased (in shares)	0.3	0.4	'
Common stock repurchased	$25	$14.60	'
Available for repurchase under the repurchase program	'	'	$369.50

SEGMENT_INFORMATION_Details

SEGMENT INFORMATION (Details) (USD $)

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

In Thousands, unless otherwise specified

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Dec. 31, 2013

Mar. 31, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Dec. 31, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2013

Sep. 30, 2012

Jun. 30, 2014

Jun. 30, 2013

Dec. 31, 2013

Mar. 31, 2013

Sep. 30, 2012

Jun. 30, 2014

Jun. 30, 2013

Dec. 31, 2013

Region

North Asia [Member]

Greater China [Member]

Americas [Member]

South Asia/Pacific [Member]

Europe - By Region [Member]

Japan [Member]

South Korea [Member]

Hong Kong [Member]

United States [Member]

Mainland China [Member]

Taiwan [Member]

Malaysia [Member]

ProductLine

SEGMENT INFORMATION [Abstract]

Number of geographic regions

Number of product lines

Revenues from External Customers and Long-Lived Assets [Line Items]

Revenue

$650,027

$671,328

$1,321,088

$1,212,633

$195,995

$194,812

$391,456

$380,722

$229,869

$261,241

$508,798

$432,063

$89,911

$83,433

$169,820

$159,125

$81,653

$85,582

$152,847

$152,539

$52,599

$46,260

$98,167

$88,184

$77,198

$97,392

$158,659

$202,207

$118,797

$97,420

$232,797

$178,515

$34,410

$33,034

$65,358

$52,065

$61,056

$61,627

$115,878

$118,674

$153,795

$190,383

$366,012

$310,048

$41,664

$37,824

$77,428

$69,950

$23,256

$27,797

$42,305

$45,840

Long-lived assets

$12,629

$9,970

$24,834

$14,345

$2,282

$2,497

$281,426

$273,388

$95,552

$82,726

$1,939

$1,928

$1,267

$1,463

SEGMENT_INFORMATION_Products_a

SEGMENT INFORMATION, Products and Services (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Revenue from External Customer [Line Items]	'	'	'	'
Revenue	$650,027	$671,328	$1,321,088	$1,212,633
Nu Skin [Member]	'	'	'	'
Revenue from External Customer [Line Items]	'	'	'	'
Revenue	391,968	411,220	794,079	732,660
Pharmanex [Member]	'	'	'	'
Revenue from External Customer [Line Items]	'	'	'	'
Revenue	256,216	258,862	523,488	477,213
Other Product Lines [Member]	'	'	'	'
Revenue from External Customer [Line Items]	'	'	'	'
Revenue	$1,843	$1,246	$3,521	$2,760

DEFERRED_TAX_ASSETS_AND_LIABIL1

DEFERRED TAX ASSETS AND LIABILITIES (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
DEFERRED TAX ASSETS AND LIABILITIES [Abstract]	'	'
Net deferred tax assets	$61.70	'
Accumulated reinvested foreign earnings	50	50
Incremental taxes on indefinitely reinvested foreign earnings	$5.50	'

UNCERTAIN_TAX_POSITIONS_Detail

UNCERTAIN TAX POSITIONS (Details) (USD $)	Jun. 30, 2014
In Millions, unless otherwise specified	Jun. 30, 2014
UNCERTAIN TAX POSITIONS [Abstract]	'
Estimate of change in gross unrecognized tax benefits, net of foreign currency adjustments, within the next 12 months - minimum	$3
Estimate of change in gross unrecognized tax benefits, net of foreign currency adjustments, within the next 12 months - maximum	$4

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Details)	Jun. 30, 2014	Jun. 30, 2014
In Millions, unless otherwise specified	USD ($)	JPY (¥)
Loss Contingencies [Line Items]	'	'
Aggregate amount of assessments and disputed duties	$42.10	¥ 4,300

DEBT_Details

DEBT (Details)

6 Months Ended

0 Months Ended

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Aug. 08, 2014

Jun. 30, 2014

Feb. 05, 2014

Dec. 31, 2013

Feb. 05, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Apr. 09, 2014

USD ($)

Multi-currency uncommitted shelf facility, U.S. dollar denominated 1 [Member]

Multi-currency uncommitted shelf facility, U.S. dollar denominated 2 [Member]

Multi-currency uncommitted shelf facility, total U.S. dollar-denominated debt [Member]

Multi-Currency Uncommitted Shelf Facility, Japanese Yen Denominated 1 [Member]

Multi-Currency Uncommitted Shelf Facility, Japanese Yen Denominated 2 [Member]

Multi-Currency Uncommitted Shelf Facility, Japanese Yen Denominated 3 [Member]

Multi-Currency Uncommitted Shelf Facility, Japanese Yen Denominated 4 [Member]

Multi-currency uncommitted shelf facility, total Japanese yen-denominated debt [Member]

Multi-currency uncommitted shelf facility, Total [Member]

Revolving credit facility 2010 [Member]

Revolving Credit facility 2013 [Member]

Revolving Credit Facility 2014 [Member]

Revolving Line Of Credit 364 Day [Member]

USD ($)

JPY (¥)

USD ($)

JPY (¥)

USD ($)

JPY (¥)

USD ($)

JPY (¥)

USD ($)

JPY (¥)

USD ($)

JPY (¥)

USD ($)

JPY (¥)

USD ($)

JPY (¥)

USD ($)

Subsequent Event [Member]

USD ($)

Subsequent Event [Member]

USD ($)

Debt Instrument [Line Items]

Original principal amount - facilities

$40,000,000

$20,000,000

¥ 3,100,000,000

¥ 2,300,000,000

¥ 2,200,000,000

¥ 8,000,000,000

Balance - facilities

17,100,000

[1]

17,100,000

8,600,000

[1]

11,400,000

[1]

4,100,000

[1]

400,000,000

12,800,000

1,300,000,000

[1]

12,300,000

1,300,000,000

9,200,000

900,000,000

[1]

11,800,000

1,200,000,000

78,700,000

[1]

8,000,000,000

[1]

75,800,000

8,000,000,000

35,000,000

[1],[2],[3]

35,000,000

14,000,000

Interest rate - facilities (in hundredths)

6.20%

1.70%

2.60%

3.30%

1.70%

Repayment terms

'Notes due July 2016 with annual principal payments that began in July 2010.

'Notes due January 2017 with annual principal payments that began in January 2011.

'Notes paid in full on April 30, 2014

'Notes due September 2017 with annual principal payments that began in September 2011.

'Notes due January 2017 with annual principal payments that began in January 2011.

'Notes due May 2022 with annual principal payments that begin in May 2016.

'Revolving line of credit expired August 8, 2014.

[2]

'Revolving line of credit expires September 2014.

[2]

'Revolving line of credit expires April 2015.

Balance - other borrowings

6,200,000

85,000,000

50,000,000

Interest rate description - other borrowings

'Variable 30 day: 0.66%

[2]

'Variable 30 day: 0.5783%

Interest rate - other borrowings (in hundredths)

0.66%

[2]

0.58%

Maturity Date

1-May-22

Current portion of long-term debt

99,828,000

67,824,000

8,600,000

50,000,000

[2]

Restricted payments covenant threshold for making dividend payments or stock repurchases

$110,000,000

$100,000,000

Variable rate basis

'1 month LIBOR

Variable rate (in hundredths)

0.95%

[1]

The current portion of the Companybs long-term debt (i.e. becoming due in the next 12 months) includes $10.9 million of the balance of its Japanese yen-denominated debt under the multi-currency uncommitted shelf facility, $8.6 million of the balance on its U.S. dollar denominated debt under the multi-currency uncommitted shelf facility, $15.0 million of the Companybs committed loan and $35.0 million of its revolving loan.

[2]

On February 5, 2013, the Company entered into a second amendment of the amended and restated credit agreement. The amendment increased the commitment amount from $25.0 million to $100.0 million from February 2013 to February 2014, after which the commitment amount returns to the current level over a three-month period.

[3]

The committed loan is secured by deeds of trust with respect to the Companybs corporate headquarters and distribution center in Provo, Utah.

REVISIONS_Details

REVISIONS (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Other income (expense), net	($21,119)	($1,187)	($38,627)	($1,075)	'
Accumulated other comprehensive loss	-42,284	'	-42,284	'	-46,228
Prepaid expenses and other	180,957	'	180,957	'	162,886
Net income	19,507	74,435	74,361	128,717	'
Comprehensive Income	22,086	74,535	78,305	125,267	'
Net increase in cash and cash equivalents	'	'	-305,652	82,653	'
Selling expenses	283,575	297,170	596,676	530,264	'
Revenue	650,027	671,328	1,321,088	1,212,633	'
Operating income	54,737	114,583	155,934	197,242	'
Total assets	1,603,614	'	1,603,614	'	1,821,062
Total liabilities and stockholders' equity	1,603,614	'	1,603,614	'	1,821,062
Correct Error in Classification of Selling Rebates [Member]	'	'	'	'	'
Selling expenses	-11,600	'	-11,600	'	'
Revenue	($20,400)	'	($20,400)	'	'

VENEZUELA_HIGHLY_INFLATIONARY_1

VENEZUELA HIGHLY INFLATIONARY ACCOUNTING (Details)

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2013

Dec. 31, 2012

Mar. 31, 2014

Jun. 30, 2014

Mar. 31, 2014

Jun. 30, 2014

Mar. 31, 2014

Jun. 30, 2014

USD ($)

Venezuela [Member]

Subsidiary in Venezuela [Member]

Other Income (Expense), Net [Member]

Correct Certain Accounting Errors for Hyper-Inflationary Adjustments with Respect to Operations in Venezuela [Member]

Mechanism

SICAD I [Member]

USD ($)

Maximum [Member]

Subsidiary in Venezuela [Member]

USD ($)

Minimum [Member]

VEB

SICAD I [Member]

USD ($)

Total assets

$1,603,614,000

$1,821,062,000

$7,400,000

Monetary assets

219,501,000

525,153,000

402,678,000

320,025,000

5,800,000

Payable to parent company

27,100,000

Percentage of revenue from subsidiary (in hundredths)

2.00%

Cumulative inflation rate (n hundredths)

100.00%

Period used to determine highly inflationary economy

'3 years

Adjustment to accumulated other comprehensive income (equity)

6,200,000

Out-of-period adjustment to income statement

6,200,000

Number of foreign exchange mechanisms

Number of legal mechanisms

Foreign currency exchange rate

10.7

Translation of monetary assets and liabilities

$25,000,000

$14,700,000

ADJUSTMENT_TO_INVENTORY_Detail

ADJUSTMENT TO INVENTORY (Details) (USD $)	6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2013	Jun. 30, 2014	Dec. 31, 2013
ADJUSTMENT TO INVENTORY [Abstract]	'	'	'
Write-down of inventory	$50	'	'
Total adjustments to inventory carrying value	'	$58	$5.90

SUBSEQUENT_EVENT_Details

SUBSEQUENT EVENT (Details) (Subsequent Event [Member])	1 Months Ended
In Millions, unless otherwise specified	Jul. 31, 2014	Jul. 31, 2014	Jul. 31, 2014	Aug. 08, 2014	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2014
	Subsidiary in Japan [Member]	Subsidiary in Japan [Member]	Subsidiary in South Korea [Member]	Multi-currency uncommitted shelf facility [Member]	Multi-currency uncommitted shelf facility [Member]	Multi-currency uncommitted shelf facility [Member]	Multi-currency uncommitted shelf facility [Member]
	USD ($)	JPY (¥)	USD ($)	USD ($)	USD ($)	Quarter Ending June 30, 2014 [Member]	Quarter Ending September 30, 2014 [Member]
						USD ($)	USD ($)
Subsequent Event [Line Items]	'	'	'	'	'	'	'
Restricted payments covenant threshold for making dividend payments or stock repurchases	'	'	'	$110	$100	$110	$50
Borrowings by subsidiary	$30	¥ 3,000	$20	'	'	'	'
Period of extended term	'	'	'6 months	'	'	'	'